Palavra-chave: CML

ENACT TKI SURVIVAL BCR/ABL STEM CELL TRANSPLANTATION MULTICENTER STUDY GENERIC IMATINIB BCR-ABL1 NILOTINIB PEDIATRIC PATIENTS ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION TFR CARDIOVASCULAR EVENTS F359V PIOGLITAZONE SARS-COV-2 DISCONTINUATION TRIAL FIRST LINE TERAPHY COMORBIDITIES PREGNANCY NON-MYELOABLATIVE CARDIOVASCULAR RISK BCR/ABL GENE CARDIOVASCULAR NILOTINIBE BCR-ABL PATIENTS IN BRAZIL HOCT1 CYTOGENETIC REMISSION PBSC EDI-PIO BCR-ABL MUTATIONS CHRONIC MYELOID LEUKEMIA CHRONIC MYELOID LEUKAEMIA GENE SEPT5 CHRONIC PHASE D-HPLC DASATINIBE WHO LOW EDUCATION LEVEL CHILDREN AND ADOLESCENTS DASATINIB THIRD-LINE TKI TREATMENT TYROSINE KINASE INHIBITORS BRAZIL PERIPHERAL BLOOD STEM CELLS TRANSPLANTATION HMGCLL1 2022 ALLOGENEIC BONE MARROW IMATINIB BONE MARROW TRANSPLANTATION